TY - JOUR
AU - L. Bierce
AU - A. R. Tabachnick
AU - R. D. Eiden
AU - M. Dozier
AU - M. H. Labella
A1 - 
AD - Department of Psychological Sciences, William and Mary, 540 Landrum Drive, Williamsburg, VA 23185, United States. Electronic address: lfbierce@wm.edu.; Department of Medicine, University of Illinois at Chicago, 1200 W Harrison Street, Chicago, IL, 60607, United States.; Department of Psychology and the Social Science Research Institute, The Pennsylvania State University, 140 Moore Building, University Park, PA 16801, United States.; Department of Psychological & Brain Sciences, University of Delaware, 108 Wolf Hall, Newark, DE 19717, United States.; Department of Psychological Sciences, William and Mary, 540 Landrum Drive, Williamsburg, VA 23185, United States. Electronic address: mhlabella@wm.edu.
AN - 37054901
BT - Neurotoxicol Teratol
C5 - Opioids & Substance Use; Healthcare Disparities; Measures
DA - May-Jun
DO - 10.1016/j.ntt.2023.107176
DP - NLM
ET - 20230411
JF - Neurotoxicol Teratol
LA - eng
PY - 2023
SN - 0892-0362 (Print); 0892-0362
SP - 107176
ST - A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use
T1 - A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use
T2 - Neurotoxicol Teratol
TI - A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use
U1 - Opioids & Substance Use; Healthcare Disparities; Measures
U3 - 10.1016/j.ntt.2023.107176
VL - 97
VO - 0892-0362 (Print); 0892-0362
Y1 - 2023
ER -